[go: up one dir, main page]

GB1476624A - Tranquiliser medicaments - Google Patents

Tranquiliser medicaments

Info

Publication number
GB1476624A
GB1476624A GB2575073A GB2575073A GB1476624A GB 1476624 A GB1476624 A GB 1476624A GB 2575073 A GB2575073 A GB 2575073A GB 2575073 A GB2575073 A GB 2575073A GB 1476624 A GB1476624 A GB 1476624A
Authority
GB
United Kingdom
Prior art keywords
antioxidant
tranquiliser
medicaments
ester
methyl arachidonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2575073A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CEPBEPE
Original Assignee
CEPBEPE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CEPBEPE filed Critical CEPBEPE
Priority to GB2575073A priority Critical patent/GB1476624A/en
Priority to FR7417692A priority patent/FR2231379B1/fr
Priority to DE19742425988 priority patent/DE2425988A1/en
Publication of GB1476624A publication Critical patent/GB1476624A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1476624 Antianxiety preparations CENTRE D'ETUDES EXPERIMENTALES ET CLINIQUES DE PHYSIO-BIOLOGIE DE PHARMACOLOGIE ET D'EUTONOLOGIE 24 May 1974 [30 May 1973] 25750/73 Heading A5B A medicament for combatting excitation and anxiety comprises (a) arachidonic acid or an ester thereof and (b) an antioxidant. The antioxidant may be vitamin E or glutathione. The preferred ester is methyl arachidonate. In Example methyl arachidonate is separately mixed with amphetomine and aspirin.
GB2575073A 1973-05-30 1973-05-30 Tranquiliser medicaments Expired GB1476624A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB2575073A GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments
FR7417692A FR2231379B1 (en) 1973-05-30 1974-05-21
DE19742425988 DE2425988A1 (en) 1973-05-30 1974-05-30 DRUG TO COMBAT EXCITATION AND ANGEL SYNDROME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2575073A GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments

Publications (1)

Publication Number Publication Date
GB1476624A true GB1476624A (en) 1977-06-16

Family

ID=10232682

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2575073A Expired GB1476624A (en) 1973-05-30 1973-05-30 Tranquiliser medicaments

Country Status (3)

Country Link
DE (1) DE2425988A1 (en)
FR (1) FR2231379B1 (en)
GB (1) GB1476624A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831507A1 (en) * 1978-05-26 1979-11-29 Wellcome Found FORMULATIONS CONTAINING (ALL-Z) -5,8,11,14,17-EICOSAPENTAIC ACID AND / OR THEIR DERIVATIVES AND METHOD OF PREPARATION
EP0087865A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
AU663923B2 (en) * 1992-04-08 1995-10-26 Transcend Therapeutics, Inc Method and composition for treating immune disorders, inflammation and chronic infections
WO2005107875A2 (en) * 2004-05-12 2005-11-17 Ketocytonyx Inc. Triglycerides, fatty acids, alcohols as cns modulators
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205076A (en) * 1982-08-09 1985-04-30 Univ California Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
IL69782A (en) * 1982-09-22 1987-12-20 Sentrachem Ltd Compositions for preventing cancerous conditions comprising precursors of eicosanoid mixtures and a dietary supplement containing them
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
FR2573653B1 (en) * 1984-11-23 1988-02-26 Pf Medicament ANTIANDROGEN PHARMACEUTICAL COMPOSITIONS BASED ON FATTY ACIDS
FR2581310B1 (en) * 1985-05-02 1988-09-23 Natura Medica Laboratoires THERAPEUTIC COMPOSITION COMPRISING A-LINOLENIC ACID AND A COMPOUND CAPABLE OF PROMOTING ACID THROUGH THE CELL MEMBRANE AND PLANT EXTRACT COMPRISING THE ACID AND THE COMPOUND
DE3615710A1 (en) * 1986-05-09 1987-11-26 Hoechst Ag PREPARATIONS FOR THE SYNTHESIS OF PROSTAGLANDINES AND HYDROXY FATTY ACIDS IN BIOLOGICAL SYSTEMS
DE3719097C1 (en) * 1987-06-06 1988-06-09 Fratzer Uwe Medicament containing eicosapentaenoic acid and docosahexaenoic acid as unsaturated fatty acids as well as vitamin E.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831507A1 (en) * 1978-05-26 1979-11-29 Wellcome Found FORMULATIONS CONTAINING (ALL-Z) -5,8,11,14,17-EICOSAPENTAIC ACID AND / OR THEIR DERIVATIVES AND METHOD OF PREPARATION
EP0087865A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical composition
EP0087865B1 (en) * 1982-03-01 1986-10-01 Efamol Limited Pharmaceutical composition
AU663923B2 (en) * 1992-04-08 1995-10-26 Transcend Therapeutics, Inc Method and composition for treating immune disorders, inflammation and chronic infections
WO2005107875A2 (en) * 2004-05-12 2005-11-17 Ketocytonyx Inc. Triglycerides, fatty acids, alcohols as cns modulators
WO2005107875A3 (en) * 2004-05-12 2006-03-23 Ketocytonyx Inc Triglycerides, fatty acids, alcohols as cns modulators
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds

Also Published As

Publication number Publication date
DE2425988A1 (en) 1974-12-19
FR2231379A1 (en) 1974-12-27
FR2231379B1 (en) 1977-12-23

Similar Documents

Publication Publication Date Title
GB1476624A (en) Tranquiliser medicaments
ATE56358T1 (en) CHLOROFLUOROCARBON PROPELLANT AEROSOL PAPRATES CONTAINING MEDICINAL PRODUCTS.
DE3669103D1 (en) MEDICINAL PRODUCT CONTAINING IBUPROFEN.
YU45346B (en) Process for obtaining pharmaceutical active 1-substituted oxindole-3-carboxamide
IN164030B (en)
DE3579128D1 (en) 13-CIS-VITAMIN-A-ACID AS MEDICINAL PRODUCTS CONTAINING ACTIVE SUBSTANCE.
ES2051678T1 (en) DERIVATIVES OF 5-OXO-L-PROLINE AND PHARMACEUTICAL USE THEREOF.
FR2393580A1 (en) BLOOD CONSERVATION SYSTEM
FR2321892A1 (en) PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING NANDROLONE-17B ESTER AND NEW NANDROLONE-17B ESTERS
FR2381521A1 (en) BASIS FOR MEDICINAL PREPARATIONS FOR EXTERNAL USE, MEDICINAL PREPARATIONS PREPARED BY THE AID AND PROCESS FOR THEIR PREPARATION
ES512808A0 (en) "A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION THAT PROVIDES AN ANTI-INFLAMMATORY AND ANALGESIC EFFECT TOGETHER WITH MINIMIZED GASTRIC DAMAGE".
ES2090712T3 (en) ACUTE MEDICINE CONTAINING IBUPROPHEN AND ITS USE.
IE39671B1 (en) Medicament containing a higher alkanol
BG50375A3 (en) Gelatine capsule
ES2090703T3 (en) ACUTE MEDICINE CONTAINING FLURBIPROPHEN AND ITS EMPLOYMENT.
DK165880C (en) ANDROSTAN-17BETA CARBOXYLIC ACID ESTERS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
GB1188846A (en) Thiazole Derivatives
GB1195200A (en) Pharmaceutical Compositions.
AU3080092A (en) Slow-release ibuprofen-containing medicament and its use
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
GB1152627A (en) Improvements in or relating to Oxazole Derivatives
GB1497826A (en) Analgesic preparations of intensified activity
Emmelot et al. Fatty acid oxidation in malignant and normal livers. IV. The mechanism of the stimulatory effect of some alpha-oxy-acids on fatty acid oxidation in cellfree tissue preparations of normal livers
DE3665061D1 (en) Anthranilic acid ester derivatives and anti-inflammatory and analgesic external preparations containing the same
NL7903434A (en) DERIVATIVES OF BENZOYLPHENOXYALKAN CARBON ACIDS WITH ANTI-LIPEMIC AND ANTICHOLESTEROLEMIC ACTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUND.

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee